ES2516717T3 - Proteína activadora de GM2 en orina como marcador de fallo renal agudo o de riesgo de desarrollar fallo renal agudo - Google Patents
Proteína activadora de GM2 en orina como marcador de fallo renal agudo o de riesgo de desarrollar fallo renal agudo Download PDFInfo
- Publication number
- ES2516717T3 ES2516717T3 ES09779547.0T ES09779547T ES2516717T3 ES 2516717 T3 ES2516717 T3 ES 2516717T3 ES 09779547 T ES09779547 T ES 09779547T ES 2516717 T3 ES2516717 T3 ES 2516717T3
- Authority
- ES
- Spain
- Prior art keywords
- renal failure
- acute renal
- risk
- urine
- marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9446—Antibacterials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Abstract
Metodo para proporcionar datos para determinar el riesgo de un individuo de desarrollar fallo renal agudo (FRA), o para determinar FRA, que comprende la deteccion y/o cuantificacion de una proteina al menos un 70% o 100% identica a la SEQ ID NO: 1, en una muestra biologica aislada de un individuo (sujeto), preferiblemente el individuo es un humano.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2009/056381 WO2010136059A1 (en) | 2009-05-26 | 2009-05-26 | Urinary gm2 activator protein as a marker of acute renal failure or the risk of developing acute renal failure |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2516717T3 true ES2516717T3 (es) | 2014-10-31 |
Family
ID=41134567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09779547.0T Active ES2516717T3 (es) | 2009-05-26 | 2009-05-26 | Proteína activadora de GM2 en orina como marcador de fallo renal agudo o de riesgo de desarrollar fallo renal agudo |
Country Status (6)
Country | Link |
---|---|
US (1) | US20120129721A1 (es) |
EP (1) | EP2435826B1 (es) |
JP (1) | JP5736597B2 (es) |
CA (1) | CA2763496A1 (es) |
ES (1) | ES2516717T3 (es) |
WO (1) | WO2010136059A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2766228A1 (en) * | 2009-07-02 | 2011-01-06 | Mosaiques Diagnostics And Therapeutics Ag | Process and markers for the diagnosis of acute renal failure |
RU2599099C1 (ru) * | 2015-08-17 | 2016-10-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития острой почечной недостаточности по уровню экспрессии генов casp3, casp8 и casp9 после кратковременной ишемии почки |
US11007253B2 (en) | 2015-12-18 | 2021-05-18 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
WO2018107700A1 (zh) * | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗病理性肾组织损伤的方法 |
WO2019091773A1 (en) * | 2017-11-08 | 2019-05-16 | Tetra Laval Holdings & Finance S.A. | A method of determining a microbiological risk level in a food batch |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7469185B2 (en) | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
US7951545B2 (en) * | 2002-04-30 | 2011-05-31 | Seikagaku Corporation | Method for detecting lysosomal storage diseases |
FR2864086A1 (fr) * | 2003-12-23 | 2005-06-24 | Biomerieux Sa | Facteur cytotoxique isole associe a la sclerose en plaques et procede de detection dudit facteur cytotoxique |
US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
-
2009
- 2009-05-26 WO PCT/EP2009/056381 patent/WO2010136059A1/en active Application Filing
- 2009-05-26 JP JP2012512212A patent/JP5736597B2/ja not_active Expired - Fee Related
- 2009-05-26 EP EP09779547.0A patent/EP2435826B1/en not_active Not-in-force
- 2009-05-26 ES ES09779547.0T patent/ES2516717T3/es active Active
- 2009-05-26 CA CA2763496A patent/CA2763496A1/en not_active Abandoned
- 2009-05-26 US US13/322,378 patent/US20120129721A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2435826A1 (en) | 2012-04-04 |
US20120129721A1 (en) | 2012-05-24 |
JP2012528300A (ja) | 2012-11-12 |
EP2435826B1 (en) | 2014-05-21 |
CA2763496A1 (en) | 2010-12-02 |
WO2010136059A1 (en) | 2010-12-02 |
JP5736597B2 (ja) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2516717T3 (es) | Proteína activadora de GM2 en orina como marcador de fallo renal agudo o de riesgo de desarrollar fallo renal agudo | |
Bakos et al. | Developmental toxicity and estrogenic potency of zearalenone in zebrafish (Danio rerio) | |
Wang et al. | Development of aquatic life criteria for triclosan and comparison of the sensitivity between native and non-native species | |
CL2013002907A1 (es) | Acido nucleico aislado del virus de peces prv; polipeptido aislado; anticuerpo que se une a dicho polipeptido; metodo para determinar la presencia o ausencia de prv en una muestra biologica; arn interferente; y uso para reducir los niveles de proteina viral en una celula de un animal (div.sol.n°822-12). | |
ECSP088586A (es) | Composición de la garrapata incluyendo las garrapatas glycyphagidae y phytoseiid, su utilización, método de crianza de la garrapata depredadora phytoseiid, sistema de crianza para la mencionada garrapata depredadora phytoseiid y métodos para control | |
ES2484142T3 (es) | Diagnóstico molecular y clasificación del melanoma maligno | |
FR2912600B1 (fr) | Methode et systeme de retassage d'un plateau d'oeufs | |
WO2008089994A8 (en) | Use of igfbp-7 in the assessment of heart failure | |
EA200701427A1 (ru) | Композиция клещей, её применение, способ разведения хищного клеща - фитосейида, система для разведения указанного хищного клеща - фитосейида и способы биологического контроля вредителей в культуре | |
Manerikar et al. | In vitro and in vivo genotoxicity assessment of Cr (VI) using comet assay in earthworm coelomocytes | |
ES2422597T3 (es) | Membrana de ensayo y método de uso de la misma | |
CY1119262T1 (el) | Αναλυτικες μεθοδοι και συστοιχιες για χρηση στην ταυτοποιηση παραγοντων που επαγουν ευαισθητοποιηση στο ανθρωπινο δερμα | |
CL2010000720A1 (es) | Método para la evaluar la respuesta a la inhibición de her en una muestra de paciente, que comprende detectar la proteina marcadora egf (div.sol.no. 1240-06). | |
EP2520935A3 (en) | Organ-specific proteins and methods of their use | |
PE20131062A1 (es) | Uso de hmgb1 como marcador biologico de afecciones intestinales inflamatorias, metodo no invasivo para su deteccion en muestras fecales y kit para su realizacion | |
BRPI0915619A2 (pt) | métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra | |
DE602005006990D1 (de) | Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen | |
BRPI0916624A2 (pt) | anticorpos monoclonais seletivos anti-hepcidina-25, seus usos, bem como método e kit para quantificar a quantidade de proteína hepcidina-25 em uma amostra de tecido ou fluido biológico | |
BR112012014925A2 (pt) | compostos promotores de replicação de células beta e métodos de uso dos mesmos | |
DE602007005665D1 (de) | Gerät zur entnahme von biologischen gewebeproben zur identifizierung von tieren | |
Mabrouk et al. | Fluctuating asymmetry in grass goby Zosterisessor ophiocephalus Pallas, 1811 inhabiting polluted and unpolluted area in Tunisia | |
Wang et al. | The effect of fluorine exposure on morphological indicators and intestinal microbial community in Bufo gargarizans tadpoles | |
ES2530567T3 (es) | Método para identificar un sujeto susceptible de desarrollar insuficiencia cardíaca determinando el nivel de galectina-3 o trombospondina-2 | |
PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
ES2619569T3 (es) | Método de ensayo de infección o inflamación de las vías respiratorias inferiores |